Comparison of the Effects of Metoclopramide and Ondansetron on Emergency Service Observation Times in Acute Gastroenteritis-Related Nausea and Vomiting Cases
- PMID: 32377080
- PMCID: PMC7199832
- DOI: 10.14744/SEMB.2019.80217
Comparison of the Effects of Metoclopramide and Ondansetron on Emergency Service Observation Times in Acute Gastroenteritis-Related Nausea and Vomiting Cases
Abstract
Objectives: The aim of the present study was to compare the effect of metoclopramide and ondansetron treatments on the emergency department observation time in acute gastroenteritis-related nausea and vomiting (NV).
Methods: The study was conducted retrospectively on 297 patients diagnosed with acute gastroenteritis in a training and research hospital's emergency service observation unit within 6 months. Patients with gastroenteritis who were diagnosed with NV were divided into two groups according to the treatment they received in the observation unit. Patients who received 4 mg ondansetron slow infusion therapy were classified as Group 1, and patients who received 10 mg metoclopramide slow infusion therapy were classified as Group 2.
Results: The average age of the patients was 39.57±18.75 years. Of the 297 participants, 56.6% (168) were female. Among them, 51.5% (153) received ondansetron (Group 1), and 48.5% (144) received metoclopramide (Group 2). 6.9% weakness-numbness and 4.9% akathisia were detected due to metoclopramide use. There were no adverse effects related to ondansetron use. The duration of observation ranged from 19 to 75 min in Group 1 and from 42 to 122 min in Group 2. Nineteen (13.2%) patients in Group 2 and 5 (3.3%) patients in Group 1 revisited the emergency department within 24 h due to ongoing complaints.
Conclusion: In conclusion, side effects of weakness and akathisia due to metoclopramide use were observed. However, no side effects were observed due to ondansetron use. Additionally, the use of ondansetron showed a shorter observation time and less recurrent admission to the emergency department. Therefore, ondansetron is a more effective drug in the treatment of NV associated with acute gastroenteritis.
Keywords: Gastroenteritis; metoclopramide; nausea; ondansetron; vomiting.
Copyright: © 2019 by The Medical Bulletin of Sisli Etfal Hospital.
Conflict of interest statement
Conflict of Interest: None declared.
Similar articles
-
Metoclopramide versus ondansetron for the treatment of vomiting in children with acute gastroenteritis.J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):156-60. doi: 10.1097/MPG.0b013e3182132d8d. J Pediatr Gastroenterol Nutr. 2011. PMID: 21788756 Clinical Trial.
-
Antiemetic use for nausea and vomiting in adult emergency department patients: randomized controlled trial comparing ondansetron, metoclopramide, and placebo.Ann Emerg Med. 2014 Nov;64(5):526-532.e1. doi: 10.1016/j.annemergmed.2014.03.017. Epub 2014 May 10. Ann Emerg Med. 2014. PMID: 24818542 Clinical Trial.
-
A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis.Ann Emerg Med. 2002 Apr;39(4):397-403. doi: 10.1067/mem.2002.122706. Ann Emerg Med. 2002. PMID: 11919526 Clinical Trial.
-
Comparing the Efficacy of Ondansetron, Domperidone, and Metoclopramide in Treating Vomiting in Pediatric Patients With Acute Gastroenteritis: A Network Meta-Analysis.Cureus. 2024 Aug 27;16(8):e67902. doi: 10.7759/cureus.67902. eCollection 2024 Aug. Cureus. 2024. PMID: 39328710 Free PMC article. Review.
-
Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.Pharmacoeconomics. 1992 Oct;2(4):285-304. doi: 10.2165/00019053-199202040-00005. Pharmacoeconomics. 1992. PMID: 10147044 Review.
Cited by
-
Prevalence and associated factors of intraoperative Nausea and Vomiting of mothers who gave birth with cesarean section under regional anesthesia: a systematic review and meta-analysis; 2023.BMC Pregnancy Childbirth. 2025 Mar 7;25(1):244. doi: 10.1186/s12884-025-07363-z. BMC Pregnancy Childbirth. 2025. PMID: 40055605 Free PMC article.
References
-
- Eken C. Current Clinical Management Suggestions:Emergency Department Management of a Patient with Acute Diarrhea. Turk J Emerg Med. 2011;1:33–9.
-
- Scuderi PE. Int Anesthesiol Clin. 2003;41:41–66. - PubMed
-
- Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Anti-emetic efficacy of prophylactic granisetron, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy:a randomized, double-blind, placebo-controlled trial. Eur J Anaesthesiol. 1998;15:166–71. - PubMed
-
- Chae J, Taylor DM, Frauman AG. Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department:A randomized, double-blinded, clinical trial. Emerg Med Australas. 2011;23:554–61. - PubMed
-
- Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology. 1992;77:162–84. - PubMed
LinkOut - more resources
Full Text Sources